66530-55-0 Suppliers

Recommended suppliers

66530-55-0 Usage

Chemical compound

6-Chloro-3-hydrazinyl-4-methylpyridazine

Functional groups

chloro and hydrazinyl

Uses

organic synthesis, pharmaceutical research, potential therapeutic agents development

Potential applications

materials science, precursor for synthesis of heterocyclic compounds

Check Digit Verification of cas no

The CAS Registry Mumber 66530-55-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,6,5,3 and 0 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 66530-55:
(7*6)+(6*6)+(5*5)+(4*3)+(3*0)+(2*5)+(1*5)=130
130 % 10 = 0
So 66530-55-0 is a valid CAS Registry Number.

66530-55-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name	6-Chloro-3-hydrazinyl-4-methylpyridazine

1.2 Other means of identification

Product number	-
Other names	(6-chloro-4-methylpyridazin-3-yl)hydrazine

1.3 Recommended use of the chemical and restrictions on use

Identified uses	For industry use only.
Uses advised against	no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number	-
Service hours	Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:66530-55-0 SDS

66530-55-0Upstream product

19064-64-3 3,6-dichloro-4-methylpyridazine

66530-55-0Downstream Products

66530-55-0Relevant academic research and scientific papers

ION CHANNEL MODULATORS

-

Paragraph 00376, (2019/12/25)

The present invention is directed to, in part, fused heteroaryl compounds and compositions useful for preventing and/or treating a disease or condition relating to aberrant function of a voltage-gated, sodium ion channel, for example, abnormal late/persistent sodium current. Methods of treating a disease or condition relating to aberrant function of a sodium ion channel including neurological disorders (e.g., Dravet syndrome, epilepsy), pain, and neuromuscular disorders are also provided herein.

PYRROLOPYRROLONE DERIVATIVES AND THEIR USE AS BET INHIBITORS

-

Page/Page column 192, (2015/06/08)

The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.

Pyrazolopyrrolidine Derivatives and their Use in the Treatment of Disease

-

Paragraph 1045; 1046, (2014/12/09)

PYRAZOLOPYRROLIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE

-

Page/Page column 216, (2014/12/12)

IMIDAZOPYRROLIDINONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE

-

Page/Page column 72; 86, (2014/12/12)

Nucleophilic substitution and lipophilicity - Structure relations in methylazolopyridazines

Katrusiak, Anna,Ratajczak-Sitarz, Malgorzata,Skierska, Urszula,Zinczenko, Wiktoria

, p. 1372 - 1386 (2007/10/03)

Syntheses of methyl[1,2,4]triazolo- or methyltetrazolopyridazine isomers, their separation and nucleophilic substitution with morpholine, dimethylamine and hydrazine have been described. The lipophilicity of the azolopyridazines has been measured and rela

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 66530-55-0

66530-55-0

Basic information

Chemical Properties

Safety Data